微创非切除性二尖瓣修复术可取得优异结局
该回顾性研究分析了2014至2017年101例接受微创非切除性二尖瓣修复的严重退行性二尖瓣反流患者,采用右小切口及股动脉插管,以人工腱索环植入和瓣环成形术修复。结果显示手术死亡率0%,1年生存率100%,3年免于复发性中度以上二尖瓣反流100%,无瓣膜相关再手术,左心房及左心室重构指标显著改善。
要点
- 微创非切除性技术修复退行性二尖瓣反流安全可行,手术死亡率低。
- 中期随访显示修复耐久性好,3年免于复发性反流达100%。
- 术后左心房和左心室逆重构明显,瓣膜跨瓣压差保持较低。
核心结论
- 微创非切除性二尖瓣修复术治疗严重退行性二尖瓣反流并发症率低、耐久性优异,并促进左心室逆重构。
研究设计与样本
- 回顾性分析2014至2017年101例连续接受微创二尖瓣修复的严重退行性二尖瓣反流患者,均经右小切口及股动脉插管,采用非切除技术(人工腱索环植入+瓣环成形术),并进行纵向超声心动图随访。
主要发现
- 中位年龄58岁(IQR 49-64),女性占31%。
- 除1例需延长胸廓切开外,其余均成功经右小切口完成手术;中位植入人工腱索4根,中位长度16 mm(IQR 14-18),瓣环尺寸中位34 mm(IQR 32-36)。
- 合并手术包括左心耳排除10例(10%)和卵圆孔未闭关闭13例(13%)。
- 中位体外循环时间152分钟(IQR 142-164),主动脉阻断时间90分钟(IQR 81-98)。
- 手术死亡率0%,1年生存率100%;3年免于复发性至少中度二尖瓣反流100%,无患者需瓣膜相关再手术。
临床怎么用
- 对于严重退行性二尖瓣反流,可考虑采用微创非切除性修复技术,该技术安全、耐久且有利于左心室逆重构。
局限性
- 本研究为回顾性分析,样本量有限(101例),随访时间较短,需更大规模及更长期研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To review the efficacy of a minimally invasive surgical technique for mitral valve (MV) repair, we analyzed a nonresectional technique for degenerative mitral regurgitation. METHODS: A retrospective analysis was performed on 101 consecutive patients who underwent a minimally invasive MV repair for severe degenerative mitral regurgitation between 2014 and 2017. All patients underwent a right lateral minithoracotomy and femoral cannulation and were repaired by a nonresectional technique using neochord loop implantation and ring annuloplasty. Patients were followed with longitudinal echocardiograms. RESULTS: The median age was 58 years (interquartile range [IQR], 49-64), and 31% were women. The procedure was successfully performed using a right minithoracotomy in all patients except for 1 who required an extended thoracotomy. A median of 4 neochords were placed. The median length was 16 mm (IQR, 14-18), and ring size was 34 mm (IQR, 32-36). Concomitant procedures included left atrial appendage exclusion in 10 patients (10%) and patent foramen ovale closure in 13 (13%). Median cardiopulmonary bypass time was 152 minutes (IQR, 142-164), and aortic cross-clamp time was 90 minutes (IQR, 81-98). Operative mortality was 0% and 1-year survival 100%. At 3 years freedom from recurrent at least moderate mitral regurgitation was 100%, and no patient required a valve-related reoperation. At 1 year the median left atrial diameter decreased by 15% (44 vs 37 mm, P < .001), the left ventricular end-diastolic diameter decreased by 14% (53 vs 46 mm, P < .001), and MV gradients remained low (3.1 vs 2.9 mmHg, P = .54). CONCLUSIONS: Minimally invasive MV repair using a nonresectional technique can be performed for severe degenerative mitral regurgitation with a low complication rate, excellent durability, and promising left ventricular reverse remodeling.
引用
- Axtell AL, Moonsamy P, Dal-Bianco JP, et al. Minimally Invasive Nonresectional Mitral Valve Repair Can Be Performed With Excellent Outcomes. Ann Thorac Surg. 2019. PMID: 31473178. doi:10.1016/j.athoracsur.2019.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。